Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 20/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5253289 | 0.92 | CNR2 (0.67) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5245452 | 0.92 | CNR2 (0.62) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5245489 | 0.91 | CNR2 (0.62) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5216734 | 0.90 | CNR2 (0.79) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5245892 | 0.89 | CNR2 (0.83) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5246529 | 0.88 | CNR2 (0.62) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5246068 | 0.88 | CNR2 (0.62) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5246123 | 0.88 | CNR2 (0.69) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5255943 | 0.87 | CNR2 (0.67) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 | |
| SCHEMBL5248180 | 0.86 | CNR2 (0.69) | CNR2CYP2C9CYP1A2CYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1565442-B1 | PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS | GLAXO GROUP LTD (GB) | 2007-11-14 | — | — | EP | claimed |